ADLS.OB: Summary for ADVANCED LIFE SCIENC - Yahoo! Singapore Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, February 10, 2010, 7:26pm SGT - The Singapore stock market is closed.

To create a watchlist or portfolio of shares, Register

FINANCE HOME PAGE

INVESTING

FINANCE NEWS

Advanced Life Sciences Holdings, Inc. (ADLS.OB)

At 4:58AM SGT: 0.16 USD 0.00 (0.00%)

MORE ON ADLS.OB

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

ADVANCED LIFE SCIENC (OTC BB:ADLS.OB) Delayed quote data

Last Trade:	0.16 USD
Trade Time:	4:58AM SGT
Change:	0.00 (0.00%)
Prev Close:	0.16
Open:	N/A
Bid:	N/A
Ask:	N/A
1y Target Est:	2.00

Day's Range:	N/A - N/A
52wk Range:	0.14 - 1.62
Volume:	0
Avg Vol (3m):	926,146
Market Cap:	12.50M
P/E (ttm):	N/A
EPS (ttm):	-0.22
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y

Use Y! Toolbar to track stocks

Add ADLS.OB to Portfolio

Download Data

HEADLINES

•	Advanced Life Sciences Previews 2010 Milestones
	PR Newswire (Wed 6:00am)

•	Advanced Life Sciences to Present at the 3rd Annual OneMedForum Emerging Company Finance Conference
	PR Newswire (Wed, Jan 6)

•	ADVANCED LIFE SCIENCES HOLDINGS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial State
	EDGAR Online (Tue, Jan 5)

•	Advanced Life Sciences' Restanza Shows 100% Survival in Tularemia Pivotal Animal Study
	PR Newswire (Wed, Dec 16)

•	ADVANCED LIFE SCIENCES HOLDINGS, INC. Financials
	EDGAR Online Financials (Sat, Nov 14)

•	Advanced Life Sciences Inc. Earnings Call scheduled for 10:00 am ET today
	CCBN (Tue, Nov 10)

•	ADVANCED LIFE SCIENCES HOLDINGS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial St
	EDGAR Online (Tue, Nov 10)

•	Trading Outlook for Advanced Life Sciences Holdings Inc. Issued by InvestorSoup.com
	GlobeNewswire (Thu, Nov 5)

•	ADVANCED LIFE SCIENCES HOLDINGS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial State
	EDGAR Online (Mon, Nov 2)

•	ADVANCED LIFE SCIENCES HOLDINGS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement
	EDGAR Online (Wed, Oct 7)

More Headlines for ADLS.OB...

ANALYST

EPS Est (next year) (Dec-09) :	N/A
EPS Est (in 2 years) (Dec-10) :	N/A
Avg Rec (current)*:	1.0
PEG Ratio:	N/A

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

Advanced Life Sciences Holdings, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of novel drugs in the areas of infectious disease, oncology, and respiratory disease.

Full Company Profile

Add to Portfolio

Email to a Friend

•